P.F. Bruning
- Oncology top 2%
- Cancer Treatment and Pharmacology 14
- Cancer Risks and Factors 5
- HER2/EGFR in Cancer Research 5
- Cancer Research top 5%
- Breast Cancer Treatment Studies 10
- Reproductive Medicine top 5%
- Dermatology top 5%
-
- Effects and risks of endocrine disrupting chemicals 7
-
- Estrogen and related hormone effects 7
-
- Nutritional Studies and Diet 5
-
- Medical Imaging Techniques and Applications 4
- Co-authors
- Martine PiccartJ. M. G. BonfrerRobert ParidaensJohannes M.G. BonfrèrLaura BiganzoliM. De Jong‐BakkerRobert E. ColemanW. Erich
- Journals
- European Journal of Cancer (7 papers)Annals of Oncology (4 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- NetherlandsBelgiumUnited Kingdom
In The Last Decade
P.F. Bruning
55 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 115
- Oncology 1.3k
- Cancer Research 522
- Reproductive Medicine 143
- Endocrinology, Diabetes and Metabolism 189
- Dermatology 99
Countries citing papers authored by P.F. Bruning
This map shows the geographic impact of P.F. Bruning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.F. Bruning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.F. Bruning more than expected).
Fields of papers citing papers by P.F. Bruning
This network shows the impact of papers produced by P.F. Bruning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.F. Bruning. The network helps show where P.F. Bruning may publish in the future.
Co-authorship network
The 25 scholars most cited alongside P.F. Bruning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 83 | |
| 2 | AT (doxorubicin-Taxol) versus AC (doxorubicin-cyclophosphamide) as first line chemotherapy in metastatic breast cancer (MBC): A phase III study. (originally presented at ASCO 2000. Abstract 282) | 2000 | 13 |
| 3 | 2000 | 137 | |
| 4 | 2000 | 49 | |
| 5 | 2000 | 288 | |
| 6 | 2000 | 42 | |
| 7 | 1997 | 95 | |
| 8 | 1997 | 2 | |
| 9 | 1995 | 55 | |
| 10 | Role of pamidronate in the management of bone metastases from breast cancer: Results of a non-comparative multicenter phase II trial | 1994 | 13 |
| 11 | 1994 | 15 | |
| 12 | 1990 | 1 | |
| 13 | Radioimmunoscintigraphy using iodine-131-anti-CEA monoclonal antibodies and thallium-201 scintigraphy in medullary thyroid carcinoma: a case report. | 1990 | 9 |
| 14 | 1990 | 10 | |
| 15 | 1989 | 16 | |
| 16 | 1988 | 3 | |
| 17 | Why is breast cancer so frequent in The Netherlands? | 1988 | 8 |
| 18 | 1988 | 14 | |
| 19 | 1988 | 19 | |
| 20 | 1987 | 38 |
About P.F. Bruning
P.F. Bruning is a scholar working on Oncology, Cancer Research, Reproductive Medicine, Orthopedics and Sports Medicine and Health, Toxicology and Mutagenesis, having authored 55 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (14 papers), Breast Cancer Treatment Studies (10 papers), Effects and risks of endocrine disrupting chemicals (7 papers), Estrogen and related hormone effects (7 papers), Cancer Risks and Factors (5 papers), Nutritional Studies and Diet (5 papers), HER2/EGFR in Cancer Research (5 papers) and Medical Imaging Techniques and Applications (4 papers). The work is most often cited by research in Oncology (1.3k citations), Cancer Research (522 citations), Reproductive Medicine (143 citations), Endocrinology, Diabetes and Metabolism (189 citations) and Dermatology (99 citations). P.F. Bruning has collaborated with scholars based in Netherlands, Belgium and United Kingdom. Frequent co-authors include Martine Piccart, J. M. G. Bonfrer, Robert Paridaens, Johannes M.G. Bonfrèr, Laura Biganzoli, M. De Jong‐Bakker, Robert E. Coleman, W. Erich, C. M. de Ridder and Maria L. Zonderland. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.